| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 7 | |
| #3 | EPO (European Patent Office) | 6 | |
| #4 | Australia | 5 | |
| #5 | Canada | 5 | |
| #6 | Republic of Korea | 3 | |
| #7 | Chile | 2 | |
| #8 | China | 2 | |
| #9 | Hungary | 2 | |
| #10 | Israel | 2 | |
| #11 | Mexico | 2 | |
| #12 | Brazil | 1 | |
| #13 | Philippines | 1 | |
| #14 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Derouazi Madiha | 41 |
| #2 | Belnoue Elodie | 39 |
| #3 | Madiha Derouazi | 3 |
| #4 | Elodie Belnoue | 3 |
| Publication | Filing date | Title |
|---|---|---|
| MX2019002968A | Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer. | |
| EP3429618A1 | Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine | |
| US2018133327A1 | Cell Penetrating Peptides and Complexes Comprising the Same |